Trial intelligence / Profile preview

Doxycycline in Shoulder Arthroplasty

NCT03115177Completed

Sponsor
Rush University Medical Center
Start
Nov 2015
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of doxycycline in Cutibacterium acnes infection (2 arms), sponsored by Rush University Medical Center. Primary endpoint: Presence of Propionibacterium acnes in Bacterial Culture at 2 weeks. Started Nov 2015; status: completed.

02

Drugs

doxycycline
03

Conditions

Cutibacterium acnes infection

Beyond the preview

Go deeper on NCT03115177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03115177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call